BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984
10 results:

  • 1. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
    Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
    Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
    [No Abstract]    [Full Text] [Related]  

  • 2. The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival.
    Wang C; Liang C
    Sci Rep; 2022 Jan; 12(1):377. PubMed ID: 35013466
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Suppression of breast cancer-associated bone loss with osteoblast proteomes via hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
    Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
    Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
    [No Abstract]    [Full Text] [Related]  

  • 4. Preventing tumor progression to the bone by induced tumor-suppressing MSCs.
    Sun X; Li K; Zha R; Liu S; Fan Y; Wu D; Hase M; Aryal UK; Lin CC; Li BY; Yokota H
    Theranostics; 2021; 11(11):5143-5159. PubMed ID: 33859739
    [No Abstract]    [Full Text] [Related]  

  • 5. Screening of disorders associated with osteosarcoma by integrated network analysis.
    Dou Y; Zhu K; Sun Z; Geng X; Fang Q
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30936265
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.
    Handa H; Kuroda Y; Kimura K; Masuda Y; Hattori H; Alkebsi L; Matsumoto M; Kasamatsu T; Kobayashi N; Tahara KI; Takizawa M; Koiso H; Ishizaki T; Shimizu H; Yokohama A; Tsukamoto N; Saito T; Murakami H
    Br J Haematol; 2017 Nov; 179(3):449-460. PubMed ID: 28770558
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Secondary head and neck cancer in patients with history of hematological malignancy.
    Chung JC; Tsang RK; To VS; Ho AC; Chan JY; Ho WK; Wei WI
    Head Neck; 2013 May; 35(5):729-32. PubMed ID: 22585675
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.
    Giuliano AE; Hawes D; Ballman KV; Whitworth PW; Blumencranz PW; Reintgen DS; Morrow M; Leitch AM; Hunt KK; McCall LM; Abati A; Cote R
    JAMA; 2011 Jul; 306(4):385-93. PubMed ID: 21791687
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cost effectiveness of zoledronic acid in the management of skeletal metastases in hormone-refractory prostate cancer patients in France, Germany, Portugal, and the Netherlands.
    Carter JA; Joshi A; Kaura S; Botteman MF
    J Med Econ; 2011; 14(3):288-98. PubMed ID: 21469915
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
    Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
    BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.